Veeva Systems (NYSE:VEEV – Get Free Report) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it contrast to its rivals? We will compare Veeva Systems to similar companies based on the strength of its valuation, profitability, institutional ownership, analyst recommendations, earnings, risk and dividends.
Valuation & Earnings
This table compares Veeva Systems and its rivals top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Veeva Systems | $3.20 billion | $908.91 million | 43.71 |
| Veeva Systems Competitors | $341.86 million | -$24.15 million | 11.30 |
Veeva Systems has higher revenue and earnings than its rivals. Veeva Systems is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Volatility and Risk
Veeva Systems has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, Veeva Systems’ rivals have a beta of 1.11, suggesting that their average share price is 11% more volatile than the S&P 500.
Insider & Institutional Ownership
88.2% of Veeva Systems shares are owned by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are owned by institutional investors. 10.6% of Veeva Systems shares are owned by company insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Profitability
This table compares Veeva Systems and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Veeva Systems | 29.34% | 14.25% | 11.71% |
| Veeva Systems Competitors | -749.77% | -27.84% | -15.02% |
Analyst Ratings
This is a summary of recent ratings and recommmendations for Veeva Systems and its rivals, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Veeva Systems | 1 | 8 | 19 | 0 | 2.64 |
| Veeva Systems Competitors | 457 | 1542 | 2763 | 90 | 2.51 |
Veeva Systems presently has a consensus target price of $316.79, indicating a potential upside of 19.19%. As a group, “Healthcare Technology” companies have a potential upside of 61.54%. Given Veeva Systems’ rivals higher possible upside, analysts clearly believe Veeva Systems has less favorable growth aspects than its rivals.
Summary
Veeva Systems beats its rivals on 9 of the 13 factors compared.
About Veeva Systems
Veeva Systems Inc. develops cloud-based software, data and consulting services for the life sciences industry. Its customers include pharmaceutical and biotechnology companies, medical device makers and contract research organizations. The company’s products support commercial operations as well as clinical, regulatory, quality and safety activities. Its offerings include Veeva Vault applications for managing documents and business processes, customer relationship management software, and data and analytics services.
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
